Medudoc is a Switzerland-based startup founded in 2018 with a clear mission of transforming the healthcare landscape through innovative patient education. Focused on personalized patient education, they offer a SaaS platform with a library of medically validated videos customized to meet unique patient needs, ultimately leading to better understanding and treatment adherence. The platform also provides automated video recommendations based on patients' specific needs, indications, and risk profiles. Medudoc also simplifies the informed consent process with advanced electronic signatures, saving valuable time for both patients and healthcare professionals. With a recent Seed Round investment in October 4th, 2022 by Max Schnoedl, Medudoc is gaining traction as a trusted partner in healthcare innovation. The startup's seamless integration into existing medical workflows through industry-standard APIs promises concrete benefits such as legal compliance for clinics, time savings for physicians, improved patient understanding, and holistic informed consent with electronic signature. With its innovative approach and concrete benefits, Medudoc presents itself as a promising player in the Health Care and SaaS industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | Unknown | 1 | Max Schnoedl | 04 Oct 2022 |
Seed Round | β¬2.00M | 3 | Martin KlΓ€ssner, Wieland Sommer +1 | 01 Jul 2022 |
Pre Seed Round | Fr.700.00K | - | 30 Jun 2020 | |
Pre Seed Round | Fr.500.00K | - | 01 Nov 2019 |
No recent news or press coverage available for medudoc | digital patient education.